<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.proteinscience.org">
<title>Protein Science current issue</title>
<link>http://www.proteinscience.org</link>
<description>Protein Science RSS feed -- current issue</description>
<prism:eIssn>1469-896X</prism:eIssn>
<prism:coverDisplayDate>Dec  1 2008 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Protein Science</prism:publicationName>
<prism:issn>0961-8368</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2023?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2038?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2051?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2059?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2070?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2080?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2091?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2101?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2111?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2120?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2127?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2134?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2145?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2156?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2167?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2174?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2180?rss=1" />
  <rdf:li rdf:resource="http://www.proteinscience.org/cgi/content/short/17/12/2187?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.proteinscience.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://www.proteinscience.org/icons/banner/title.gif">
<title>Protein Science</title>
<url>http://www.proteinscience.org/icons/banner/title.gif</url>
<link>http://www.proteinscience.org</link>
</image>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2023?rss=1">
<title><![CDATA[[REVIEWS] Unconventional serine proteases: Variations on the catalytic Ser/His/Asp triad configuration]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2023?rss=1</link>
<description><![CDATA[
<p>Serine proteases comprise nearly one-third of all known proteases identified to date and play crucial roles in a wide variety of cellular as well as extracellular functions, including the process of blood clotting, protein digestion, cell signaling, inflammation, and protein processing. Their hallmark is that they contain the so-called "classical" catalytic Ser/His/Asp triad. Although the classical serine proteases are the most widespread in nature, there exist a variety of "nonclassical" serine proteases where variations to the catalytic triad are observed. Such variations include the triads Ser/His/Glu, Ser/His/His, and Ser/Glu/Asp, and include the dyads Ser/Lys and Ser/His. Other variations are seen with certain serine and threonine peptidases of the Ntn hydrolase superfamily that carry out catalysis with a single active site residue. This work discusses the structure and function of these novel serine proteases and threonine proteases and how their catalytic machinery differs from the prototypic serine protease class.</p>
]]></description>
<dc:creator><![CDATA[Ekici, O. D., Paetzel, M., Dalbey, R. E.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.035436.108</dc:identifier>
<dc:title><![CDATA[[REVIEWS] Unconventional serine proteases: Variations on the catalytic Ser/His/Asp triad configuration]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2037</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2023</prism:startingPage>
<prism:section>REVIEWS</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2038?rss=1">
<title><![CDATA[[ARTICLES] Dynameomics: Large-scale assessment of native protein flexibility]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2038?rss=1</link>
<description><![CDATA[
<p>Structure is only the first step in understanding the interactions and functions of proteins. In this paper, we explore the flexibility of proteins across a broad database of over 250 solvated protein molecular dynamics simulations in water for an aggregate simulation time of ~6 &micro;s. These simulations are from our Dynameomics project, and these proteins represent approximately 75% of all known protein structures. We employ principal component analysis of the atomic coordinates over time to determine the primary axis and magnitude of the flexibility of each atom in a simulation. This technique gives us both a database of flexibility for many protein fold families and a compact visual representation of a particular protein's native-state conformational space, neither of which are available using experimental methods alone. These tools allow us to better understand the nature of protein motion and to describe its relationship to other structural and dynamical characteristics. In addition to reporting general properties of protein flexibility and detailing many dynamic motifs, we characterize the relationship between protein native-state flexibility and early events in thermal unfolding and show that flexibility predicts how a protein will begin to unfold. We provide evidence that fold families have conserved flexibility patterns, and family members who deviate from the conserved patterns have very low sequence identity. Finally, we examine novel aspects of highly inflexible loops that are as important to structural integrity as conventional secondary structure. These loops, which are difficult if not impossible to locate without dynamic data, may constitute new structural motifs.</p>
]]></description>
<dc:creator><![CDATA[Benson, N. C., Daggett, V.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037473.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] Dynameomics: Large-scale assessment of native protein flexibility]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2050</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2038</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2051?rss=1">
<title><![CDATA[[ARTICLES] The I{kappa}B{alpha}/NF-{kappa}B complex has two hot spots, one at either end of the interface]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2051?rss=1</link>
<description><![CDATA[
<p>IB binds to and inhibits the transcriptional activity of NF-B family members via its ankyrin repeat (AR) domain. The binding affinity of IB with NF-B(p50/p65) heterodimers and NF-B(p65/65) homodimers is in the picomolar range, and in the cell, this results in long half-lives of the complexes. Direct binding experiments have been performed using surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) on a series of truncations and mutations in order to understand what regions of the interface are most important for the tight binding affinity of this complex. We previously showed that interactions between residues 305 and 321 of NF-B(p65) with the first AR of IB are critical for the binding energy. Interactions in this region are responsible for more than 7 kcal/mol of the binding energy. Here we show equally drastic consequences for the binding energy occur upon truncation of even a few residues at the C terminus of IB. Thus, the interface actually has two hot spots, one at either end of the elongated and large surface of interaction. These results suggest a "squeeze" mechanism that leads to the extremely high affinity of the IB&bull;NF-B complex through stabilization of the ankyrin repeat domain.</p>
]]></description>
<dc:creator><![CDATA[Bergqvist, S., Ghosh, G., Komives, E. A.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037481.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] The I{kappa}B{alpha}/NF-{kappa}B complex has two hot spots, one at either end of the interface]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2058</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2051</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2059?rss=1">
<title><![CDATA[[ARTICLES] Structural and biochemical studies of TREX1 inhibition by metals. Identification of a new active histidine conserved in DEDDh exonucleases]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2059?rss=1</link>
<description><![CDATA[
<p>TREX1 is the major exonuclease in mammalian cells, exhibiting the highest level of activity with a 3'-&gt;5' activity. This exonuclease is responsible in humans for Aicardi-Gouti&egrave;res syndrome and for an autosomal dominant retinal vasculopathy with cerebral leukodystrophy. In addition, this enzyme is associated with systemic lupus erythematosus. TREX1 belongs to the exonuclease DEDDh family, whose members display low levels of sequence identity, while possessing a common fold and active site organization. For these exonucleases, a catalytic mechanism has been proposed that involves two divalent metal ions bound to the DEDD motif. Here we studied the interaction of TREX1 with the monovalent cations lithium and sodium. We demonstrate that these metals inhibit the exonucleolytic activity of TREX1, as measured by the classical gel method, as well as by a new technique developed for monitoring the real-time exonuclease reaction. The X-ray structures of the enzyme in complex with these two cations and with a nucleotide, a product of the exonuclease reaction, were determined at 2.1 &Aring; and 2.3 &Aring;, respectively. A comparison with the structures of the active complexes (in the presence of magnesium or manganese) explains that the inhibition mechanism is caused by the noncatalytic metals competing with distinct affinities for the two metal-binding sites and inducing subtle rearrangements in active centers. Our analysis also reveals that a histidine residue (His124), highly conserved in the DEDDh family, is involved in the activity of TREX1, as confirmed by mutational studies. Our results shed further light on the mechanism of activity of the DEDEh family of exonucleases.</p>
]]></description>
<dc:creator><![CDATA[Brucet, M., Querol-Audi, J., Bertlik, K., Lloberas, J., Fita, I., Celada, A.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.036426.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] Structural and biochemical studies of TREX1 inhibition by metals. Identification of a new active histidine conserved in DEDDh exonucleases]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2069</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2059</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2070?rss=1">
<title><![CDATA[[ARTICLES] Thioredoxin as a fusion tag for carrier-driven crystallization]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2070?rss=1</link>
<description><![CDATA[
<p>Structural investigations are frequently hindered by difficulties in obtaining diffracting crystals of the target protein. Here, we report the crystallization and structure solution of the U2AF homology motif (UHM) domain of splicing factor Puf60 fused to <I>Escherichia coli</I> thioredoxin A. Both modules make extensive crystallographic contacts, contributing to a well-defined crystal lattice with clear electron density for both the thioredoxin and the Puf60-UHM module. We compare two short linker sequences between the two fusion domains, GSAM and GSPPM, for which only the GSAM-linked fusion protein yielded diffracting crystals. While specific interdomain contacts are not observed for both fusion proteins, NMR relaxation data in solution indicate reduced interdomain mobility between the Trx and Puf60-UHM modules. The GSPPM-linked fusion protein is significantly more flexible, albeit both linker sequences have the same number of degrees of torsional freedom. Our analysis provides a rationale for the crystallization of the GSAM-linked fusion protein and indicates that in this case, a four-residue linker between thioredoxin A and the fused target may represent the maximal length for crystallization purposes. Our data provide an experimental basis for the rational design of linker sequences in carrier-driven crystallization and identify thioredoxin A as a powerful fusion partner that can aid crystallization of difficult targets.</p>
]]></description>
<dc:creator><![CDATA[Corsini, L., Hothorn, M., Scheffzek, K., Sattler, M., Stier, G.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037564.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] Thioredoxin as a fusion tag for carrier-driven crystallization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2079</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2070</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2080?rss=1">
<title><![CDATA[[ARTICLES] Conserved main-chain peptide distortions: A proposed role for Ile203 in catalysis by dihydrodipicolinate synthase]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2080?rss=1</link>
<description><![CDATA[
<p>In recent years, dihydrodipicolinate synthase (DHDPS, E.C. 4.2.1.52) has received considerable attention from a mechanistic and structural viewpoint. DHDPS catalyzes the reaction of (<I>S</I>)-aspartate-&beta;-semialdehyde with pyruvate, which is bound via a Schiff base to a conserved active-site lysine (Lys161 in the enzyme from <I>Escherichia coli</I>). To probe the mechanism of DHDPS, we have studied the inhibition of <I>E. coli</I> DHDPS by the substrate analog, &beta;-hydroxypyruvate. The <I>K</I> <SUB>i</SUB> was determined to be 0.21 (&plusmn;0.02) mM, similar to that of the allosteric inhibitor, (<I>S</I>)-lysine, and &beta;-hydroxypyruvate was observed to cause time-dependent inhibition. The inhibitory reaction with &beta;-hydroxypyruvate could be qualitatively followed by mass spectrometry, which showed initial noncovalent adduct formation, followed by the slow formation of the covalent adduct. It is unclear whether &beta;-hydroxypyruvate plays a role in regulating the biosynthesis of <I>meso</I>-diaminopimelate and (<I>S</I>)-lysine in <I>E. coli</I>, although we note that it is present <I>in vivo</I>. The crystal structure of DHDPS complexed with &beta;-hydroxypyruvate was solved. The active site clearly showed the presence of the inhibitor covalently bound to the Lys161. Interestingly, the hydroxyl group of &beta;-hydroxypyruvate was hydrogen-bonded to the main-chain carbonyl of Ile203. This provides insight into the possible catalytic role played by this peptide unit, which has a highly strained torsion angle ( ~201&deg;). A survey of the known DHDPS structures from other organisms shows this distortion to be a highly conserved feature of the DHDPS active site, and we propose that this peptide unit plays a critical role in catalysis.</p>
]]></description>
<dc:creator><![CDATA[Dobson, R. C.J., Griffin, M. D.W., Devenish, S. R.A., Pearce, F. G., Hutton, C. A., Gerrard, J. A., Jameson, G. B., Perugini, M. A.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037440.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] Conserved main-chain peptide distortions: A proposed role for Ile203 in catalysis by dihydrodipicolinate synthase]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2090</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2080</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2091?rss=1">
<title><![CDATA[[ARTICLES] Characterization of the steric defense of the HIV-1 gp41 N-trimer region]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2091?rss=1</link>
<description><![CDATA[
<p>During viral entry, HIV gp41 adopts a transient conformation called the "prehairpin intermediate" in which a highly conserved therapeutic target, the N-trimer, is exposed. Despite extensive discovery efforts, potent and broadly neutralizing antibodies that target the N-trimer are elusive. We previously demonstrated the N-trimer is protected by a steric block that prevents large proteins, such as antibodies, from accessing it. Here we further characterize the steric block and identify its source. To study the N-trimer steric accessibility, we produced two sets of C-peptide inhibitors (a potent inhibitor targeting the N-trimer) fused to cargo proteins of increasing size facing either the virus or cell side of the prehairpin intermediate. Both bulky inhibitor sets show a steric block, but the effect is more pronounced with virus-side cargo. Additionally, both sets maintain their potencies in a modified entry assay that removes possible sources of target cell steric hindrance. These results implicate a viral source, likely gp120, as the primary component of the steric block. In addition, we studied the steric accessibility of the "pocket" region of the N-trimer, a highly attractive drug and vaccine target. We demonstrated a pocket-specific antibody, D5, is more potent as an scFv than as a full-length IgG, suggesting the N-trimer steric restriction extends to the pocket. This characterization will facilitate the design of sterically restricted antigens that mimic the steric environment of the N-trimer in the prehairpin intermediate and are capable of inducing potent and broadly neutralizing antibodies that circumvent the N-trimer steric block.</p>
]]></description>
<dc:creator><![CDATA[Eckert, D. M., Shi, Y., Kim, S., Welch, B. D., Kang, E., Poff, E. S., Kay, M. S.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.038273.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] Characterization of the steric defense of the HIV-1 gp41 N-trimer region]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2100</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2091</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2101?rss=1">
<title><![CDATA[[ARTICLES] Proline 54 trans-cis isomerization is responsible for the kinetic partitioning at the last-step photocycle of photoactive yellow protein]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2101?rss=1</link>
<description><![CDATA[
<p>Photoactive yellow protein (PYP), a blue-light photoreceptor for <I>Ectothiorhodospira halophila</I>, has provided a unique system for studying protein folding that is coupled with a photocycle. Upon receptor activation by blue light, PYP proceeds through a photocycle that includes a partially folded signaling state. The last-step photocycle is a thermal recovery reaction from the signaling state to the native state. Bi-exponential kinetics had been observed for the last-step photocycle; however, the slow phase of the bi-exponential kinetics has not been extensively studied. Here we analyzed both fast and slow phases of the last-step photocycle in PYP. From the analysis of the denaturant dependence of the fast and slow phases, we found that the last-step photocycle proceeds through parallel channels of the folding pathway. The burial of the solvent-accessible area was responsible for the transition state of the fast phase, while structural rearrangement from the compact state to the native state was responsible for the transition state of the slow phase. The photocycle of PYP was linked to the thermodynamic cycle that includes both unfolding and refolding of the fast- and slow-phase intermediates. In order to test the hypothesis of proline-limited folding for the slow phase, we constructed two proline mutants: P54A and P68A. We found that only a single phase of the last-step photocycle was observed in P54A. This suggests that there is a low energy barrier between <I>trans</I> to <I>cis</I> conformation in P54 in the light-induced state of PYP, and the resulting <I>cis</I> conformation of P54 generates a slow-phase kinetic trap during the photocycle-coupled folding pathway of PYP.</p>
]]></description>
<dc:creator><![CDATA[Lee, B.-C., Hoff, W. D.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037655.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] Proline 54 trans-cis isomerization is responsible for the kinetic partitioning at the last-step photocycle of photoactive yellow protein]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2110</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2101</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2111?rss=1">
<title><![CDATA[[ARTICLES] Physicochemical changes in phosphorylase kinase associated with its activation]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2111?rss=1</link>
<description><![CDATA[
<p>Phosphorylase kinase (PhK) regulates glycogenolysis through its Ca<sup>2+</sup>-dependent phosphorylation and activation of glycogen phosphorylase. The activity of PhK increases dramatically as the pH is raised from 6.8 to 8.2 (denoted as pH), but Ca<sup>2+</sup> dependence is retained. Little is known about the structural changes associated with PhK's activation by pH and Ca<sup>2+</sup>, but activation by both mechanisms is mediated through regulatory subunits of the (&beta;)<SUB>4</SUB> PhK complex. In this study, changes in the structure of PhK induced by pH and Ca<sup>2+</sup> were investigated using second derivative UV absorption, synchronous fluorescence, circular dichroism spectroscopy, and zeta potential analyses. The joint effects of Ca<sup>2+</sup> and pH on the physicochemical properties of PhK were found to be interdependent, with their effects showing a strong inflection point at pH ~7.6. Comparing the properties of the conformers of PhK present under the condition where it would be least active (pH 6.8 &ndash; Ca<sup>2+</sup>) versus that where it would be most active (pH 8.2 + Ca<sup>2+</sup>), the joint activation by pH and Ca<sup>2+</sup> is characterized by a relatively large increase in the content of sheet structure, a decrease in interactions between helix and sheet structures, and a dramatically less negative electrostatic surface charge. A model is presented that accounts for the interdependent activating effects of pH and Ca<sup>2+</sup> in terms of the overall physicochemical properties of the four PhK conformers described herein, and published data corroborating the transitions between these conformers are tabulated.</p>
]]></description>
<dc:creator><![CDATA[Liu, W., Priddy, T. S., Carlson, G. M.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037895.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] Physicochemical changes in phosphorylase kinase associated with its activation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2119</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2111</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2120?rss=1">
<title><![CDATA[[ARTICLES] Novel affinity tag system using structurally defined antibody-tag interaction: Application to single-step protein purification]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2120?rss=1</link>
<description><![CDATA[
<p>Biologically important human proteins often require mammalian cell expression for structural studies, presenting technical and economical problems in the production/purification processes. We introduce a novel affinity peptide tagging system that uses a low affinity anti-peptide monoclonal antibody. Concatenation of the short recognition sequence enabled the successful engineering of an 18-residue affinity tag with ideal solution binding kinetics, providing a low-cost purification means when combined with nondenaturing elution by water-miscible organic solvents. Three-dimensional information provides a firm structural basis for the antibody&ndash;peptide interaction, opening opportunities for further improvements/modifications.</p>
]]></description>
<dc:creator><![CDATA[Nogi, T., Sangawa, T., Tabata, S., Nagae, M., Tamura-Kawakami, K., Beppu, A., Hattori, M., Yasui, N., Takagi, J.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.038299.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] Novel affinity tag system using structurally defined antibody-tag interaction: Application to single-step protein purification]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2126</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2120</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2127?rss=1">
<title><![CDATA[[ARTICLES] Preventing serpin aggregation: The molecular mechanism of citrate action upon antitrypsin unfolding]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2127?rss=1</link>
<description><![CDATA[
<p>The aggregation of antitrypsin into polymers is one of the causes of neonatal hepatitis, cirrhosis, and emphysema. A similar reaction resulting in disease can occur in other human serpins, and collectively they are known as the serpinopathies. One possible therapeutic strategy involves inhibiting the conformational changes involved in antitrypsin aggregation. The citrate ion has previously been shown to prevent antitrypsin aggregation and maintain the protein in an active conformation; its mechanism of action, however, is unknown. Here we demonstrate that the citrate ion prevents the initial misfolding of the native state to a polymerogenic intermediate in a concentration-dependent manner. Furthermore, we have solved the crystal structure of citrate bound to antitrypsin and show that a single citrate molecule binds in a pocket between the A and B &beta;-sheets, a region known to be important in maintaining antitrypsin stability.</p>
]]></description>
<dc:creator><![CDATA[Pearce, M. C., Morton, C. J., Feil, S. C., Hansen, G., Adams, J. J., Parker, M. W., Bottomley, S. P.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037234.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] Preventing serpin aggregation: The molecular mechanism of citrate action upon antitrypsin unfolding]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2133</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2127</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2134?rss=1">
<title><![CDATA[[ARTICLES] Crystal structures of Mycobacterium tuberculosis S-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitors]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2134?rss=1</link>
<description><![CDATA[
<p>S-adenosylhomocysteine hydrolase (SAHH) is a ubiquitous enzyme that plays a central role in methylation-based processes by maintaining the intracellular balance between S-adenosylhomocysteine (SAH) and S-adenosylmethionine. We report the first prokaryotic crystal structure of SAHH, from <I>Mycobacterium tuberculosis</I> (<I>Mtb</I>), in complex with adenosine (ADO) and nicotinamide adenine dinucleotide. Structures of complexes with three inhibitors are also reported: 3'-keto aristeromycin (ARI), 2-fluoroadenosine, and 3-deazaadenosine. The ARI complex is the first reported structure of SAHH complexed with this inhibitor, and confirms the oxidation of the 3' hydroxyl to a planar keto group, consistent with its prediction as a mechanism-based inhibitor. We demonstrate the in vivo enzyme inhibition activity of the three inhibitors and also show that 2-fluoradenosine has bactericidal activity. While most of the residues lining the ADO-binding pocket are identical between <I>Mtb</I> and human SAHH, less is known about the binding mode of the homocysteine (HCY) appendage of the full substrate. We report the 2.0 &Aring; resolution structure of the complex of SAHH cocrystallized with SAH. The most striking change in the structure is that binding of HCY forces a rotation of His363 around the backbone to flip out of contact with the 5' hydroxyl of the ADO and opens access to a nearby channel that leads to the surface. This complex suggests that His363 acts as a switch that opens up to permit binding of substrate, then closes down after release of the cleaved HCY. Differences in the entrance to this access channel between human and <I>Mtb</I> SAHH are identified.</p>
]]></description>
<dc:creator><![CDATA[Reddy, M. C.M., Kuppan, G., Shetty, N. D., Owen, J. L., Ioerger, T. R., Sacchettini, J. C.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.038125.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] Crystal structures of Mycobacterium tuberculosis S-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2144</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2134</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2145?rss=1">
<title><![CDATA[[ARTICLES] A double-headed cathepsin B inhibitor devoid of warhead]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2145?rss=1</link>
<description><![CDATA[
<p>Most synthetic inhibitors of peptidases have been targeted to the active site for inhibiting catalysis through reversible competition with the substrate or by covalent modification of catalytic groups. Cathepsin B is unique among the cysteine peptidase for the presence of a flexible segment, known as the occluding loop, which can block the primed subsites of the substrate binding cleft. With the occluding loop in the open conformation cathepsin B acts as an endopeptidase, and it acts as an exopeptidase when the loop is closed. We have targeted the occluding loop of human cathepsin B at its surface, outside the catalytic center, using a high-throughput docking procedure. The aim was to identify inhibitors that would interact with the occluding loop thereby modulating enzyme activity without the help of chemical warheads against catalytic residues. From a large library of compounds, the in silico approach identified [2-[2-(2,4-dioxo-1,3-thiazolidin-3-yl)ethylamino]-2-oxoethyl] 2-(furan-2-carbonylamino) acetate, which fulfills the working hypothesis. This molecule possesses two distinct binding moieties and behaves as a reversible, double-headed competitive inhibitor of cathepsin B by excluding synthetic and protein substrates from the active center. The kinetic mechanism of inhibition suggests that the occluding loop is stabilized in its closed conformation, mainly by hydrogen bonds with the inhibitor, thus decreasing endoproteolytic activity of the enzyme. Furthermore, the dioxothiazolidine head of the compound sterically hinders binding of the C-terminal residue of substrates resulting in inhibition of the exopeptidase activity of cathepsin B in a physiopathologically relevant pH range.</p>
]]></description>
<dc:creator><![CDATA[Schenker, P., Alfarano, P., Kolb, P., Caflisch, A., Baici, A.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037341.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] A double-headed cathepsin B inhibitor devoid of warhead]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2155</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2145</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2156?rss=1">
<title><![CDATA[[ARTICLES] The effects of macromolecular crowding on the mechanical stability of protein molecules]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2156?rss=1</link>
<description><![CDATA[
<p>Macromolecular crowding, a common phenomenon in the cellular environments, can significantly affect the thermodynamic and kinetic properties of proteins. A single-molecule method based on atomic force microscopy (AFM) was used to investigate the effects of macromolecular crowding on the forces required to unfold individual protein molecules. It was found that the mechanical stability of ubiquitin molecules was enhanced by macromolecular crowding from added dextran molecules. The average unfolding force increased from 210 pN in the absence of dextran to 234 pN in the presence of 300 g/L dextran at a pulling speed of 0.25 &micro;m/sec. A theoretical model, accounting for the effects of macromolecular crowding on the native and transition states of the protein molecule by applying the scaled-particle theory, was used to quantitatively explain the crowding-induced increase in the unfolding force. The experimental results and interpretation presented could have wide implications for the many proteins that experience mechanical stresses and perform mechanical functions in the crowded environment of the cell.</p>
]]></description>
<dc:creator><![CDATA[Yuan, J.-M., Chyan, C.-L., Zhou, H.-X., Chung, T.-Y., Peng, H., Ping, G., Yang, G.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037325.108</dc:identifier>
<dc:title><![CDATA[[ARTICLES] The effects of macromolecular crowding on the mechanical stability of protein molecules]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2166</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2156</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2167?rss=1">
<title><![CDATA[[PROTEIN STRUCTURE REPORTS] Novel fold of VirA, a type III secretion system effector protein from Shigella flexneri]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2167?rss=1</link>
<description><![CDATA[
<p>VirA, a secreted effector protein from <I>Shigella sp</I>., has been shown to be necessary for its virulence. It was also reported that VirA might be related to papain-like cysteine proteases and cleave -tubulin, thus facilitating intracellular spreading. We have now determined the crystal structure of VirA at 3.0 &Aring; resolution. The shape of the molecule resembles the letter "V," with the residues in the N-terminal third of the 45-kDa molecule (some of which are disordered) forming one clearly identifiable domain, and the remainder of the molecule completing the V-like structure. The fold of VirA is unique and does not resemble that of any known protein, including papain, although its N-terminal domain is topologically similar to cysteine protease inhibitors such as stefin B. Analysis of the sequence conservation between VirA and its <I>Escherichia coli</I> homologs EspG and EspG2 did not result in identification of any putative protease-like active site, leaving open a possibility that the biological function of VirA in <I>Shigella</I> virulence may not involve direct proteolytic activity.</p>
]]></description>
<dc:creator><![CDATA[Davis, J., Wang, J., Tropea, J. E., Zhang, D., Dauter, Z., Waugh, D. S., Wlodawer, A.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037978.108</dc:identifier>
<dc:title><![CDATA[[PROTEIN STRUCTURE REPORTS] Novel fold of VirA, a type III secretion system effector protein from Shigella flexneri]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2173</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2167</prism:startingPage>
<prism:section>PROTEIN STRUCTURE REPORTS</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2174?rss=1">
<title><![CDATA[[PROTEIN STRUCTURE REPORTS] Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2174?rss=1</link>
<description><![CDATA[
<p>BRD4, which is a member of the BET (bromodomains and extraterminal) protein family, interacts preferentially with acetylated chromatin and possesses multiple cellular functions in meiosis, embryonic development, the cell cycle, and transcription. BRD4 and its family members contain two bromodomains known to bind acetylated lysine, and a conserved ET domain whose function is unclear. Here we show the solution structure of the ET domain of mouse BRD4, which provides the first three-dimensional structure of an ET domain in the BET family. We determined the NMR structure of BRD4-ET with a root-mean-square deviation of 0.41 &Aring; for the backbone atoms in the structured region of residues 608&ndash;676 on the basis of 1793 upper distance limits derived from NOE intensities measured in three-dimensional NOESY spectra. The structure of the BRD4-ET domain comprises three -helices and a characteristic loop region of an irregular but well-defined structure. A DALI search revealed no close structural homologs in the current Protein Data Bank. The BRD4-ET structure has an acidic patch that forms a continuous ridge with a hydrophobic cleft, which may interact with other proteins and/or DNA.</p>
]]></description>
<dc:creator><![CDATA[Lin, Y.-J., Umehara, T., Inoue, M., Saito, K., Kigawa, T., Jang, M.-K., Ozato, K., Yokoyama, S., Padmanabhan, B., Guntert, P.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037580.108</dc:identifier>
<dc:title><![CDATA[[PROTEIN STRUCTURE REPORTS] Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2179</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2174</prism:startingPage>
<prism:section>PROTEIN STRUCTURE REPORTS</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2180?rss=1">
<title><![CDATA[[FOR THE RECORD] The interaction of CK2{alpha} and CK2{beta}, the subunits of protein kinase CK2, requires CK2{beta} in a preformed conformation and is enthalpically driven]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2180?rss=1</link>
<description><![CDATA[
<p>The protein kinase CK2 (former name: "casein kinase 2") predominantly occurs as a heterotetrameric holoenzyme composed of two catalytic chains (CK2) and two noncatalytic subunits (CK2&beta;). The CK2&beta; subunits form a stable dimer to which the CK2 monomers are attached independently. In contrast to the cyclins in the case of the cyclin-dependent kinases CK2&beta; is no on-switch of CK2; rather the formation of the CK2 holoenzyme is accompanied with an overall change of the enzyme's profile including a modulation of the substrate specificity, an increase of the thermostability, and an allocation of docking sites for membranes and other proteins. In this study we used C-terminal deletion variants of human CK2 and CK2&beta; that were enzymologically fully competent and in particular able to form a heterotetrameric holoenzyme. With differential scanning calorimetry (DSC) we confirmed the strong thermostabilization effect of CK2 on CK2&beta; with an upshift of the CK2 melting temperature of more than 9&deg;. Using isothermal titration calorimetry (ITC) we measured a dissociation constant of 12.6 nM. This high affinity between CK2 and CK2&beta; is mainly caused by enthalpic rather than entropic contributions. Finally, we determined a crystal structure of the CK2&beta; construct to 2.8 &Aring; resolution and revealed by structural comparisons with the CK2 holoenzyme structure that the CK2&beta; conformation is largely conserved upon association with CK2, whereas the latter undergoes significant structural adaptations of its backbone.</p>
]]></description>
<dc:creator><![CDATA[Raaf, J., Brunstein, E., Issinger, O.-G., Niefind, K.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037770.108</dc:identifier>
<dc:title><![CDATA[[FOR THE RECORD] The interaction of CK2{alpha} and CK2{beta}, the subunits of protein kinase CK2, requires CK2{beta} in a preformed conformation and is enthalpically driven]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2186</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2180</prism:startingPage>
<prism:section>FOR THE RECORD</prism:section>
</item>

<item rdf:about="http://www.proteinscience.org/cgi/content/short/17/12/2187?rss=1">
<title><![CDATA[[FOR THE RECORD] Amino acid composition and protein dimension]]></title>
<link>http://www.proteinscience.org/cgi/content/short/17/12/2187?rss=1</link>
<description><![CDATA[
<p>There is indirect evidence that the amino acid composition of proteins depends on their dimension. The amino acid composition of a nonredundant set of about 550,000 proteins was determined and it was observed that, in the range of 50&ndash;200 residues, the percentage of occurrence of most of the residue types significantly depends on protein dimension. This result should prove useful in analyzing protein sequences and genomics.</p>
]]></description>
<dc:creator><![CDATA[Carugo, O.]]></dc:creator>
<dc:date>2008-11-20</dc:date>
<dc:identifier>info:doi/10.1110/ps.037762.108</dc:identifier>
<dc:title><![CDATA[[FOR THE RECORD] Amino acid composition and protein dimension]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:number>12</prism:number>
<prism:volume>17</prism:volume>
<prism:endingPage>2191</prism:endingPage>
<prism:publicationDate>2008-12-01</prism:publicationDate>
<prism:startingPage>2187</prism:startingPage>
<prism:section>FOR THE RECORD</prism:section>
</item>

</rdf:RDF>